Your browser doesn't support javascript.
loading
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.
Rigau, Marc; Ostrouska, Simone; Fulford, Thomas S; Johnson, Darryl N; Woods, Katherine; Ruan, Zheng; McWilliam, Hamish E G; Hudson, Christopher; Tutuka, Candani; Wheatley, Adam K; Kent, Stephen J; Villadangos, Jose A; Pal, Bhupinder; Kurts, Christian; Simmonds, Jason; Pelzing, Matthias; Nash, Andrew D; Hammet, Andrew; Verhagen, Anne M; Vairo, Gino; Maraskovsky, Eugene; Panousis, Con; Gherardin, Nicholas A; Cebon, Jonathan; Godfrey, Dale I; Behren, Andreas; Uldrich, Adam P.
Afiliação
  • Rigau M; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Ostrouska S; University of Bonn, Bonn, Germany.
  • Fulford TS; Australian Research Council Centre of Excellence for Advanced Molecular Imaging at the University of Melbourne, Victoria 3010, Australia.
  • Johnson DN; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia.
  • Woods K; School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.
  • Ruan Z; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • McWilliam HEG; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Hudson C; Australian Research Council Centre of Excellence for Advanced Molecular Imaging at the University of Melbourne, Victoria 3010, Australia.
  • Tutuka C; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia.
  • Wheatley AK; School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.
  • Kent SJ; Ludwig Institute for Cancer Research, Melbourne -Austin Branch, Victoria 3084, Australia.
  • Villadangos JA; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Pal B; Australian Research Council Centre of Excellence for Advanced Molecular Imaging at the University of Melbourne, Victoria 3010, Australia.
  • Kurts C; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Simmonds J; Department of Biochemistry and Molecular Biology at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Pelzing M; Ludwig Institute for Cancer Research, Melbourne -Austin Branch, Victoria 3084, Australia.
  • Nash AD; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia.
  • Hammet A; School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.
  • Verhagen AM; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Vairo G; Australian Research Council Centre of Excellence for Convergent Bio-Nano Science and Technology at the University of Melbourne, Victoria 3010, Australia.
  • Maraskovsky E; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Panousis C; Australian Research Council Centre of Excellence for Convergent Bio-Nano Science and Technology at the University of Melbourne, Victoria 3010, Australia.
  • Gherardin NA; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Cebon J; Department of Biochemistry and Molecular Biology at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Godfrey DI; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia.
  • Behren A; School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.
  • Uldrich AP; University of Bonn, Bonn, Germany.
Science ; 367(6478)2020 02 07.
Article em En | MEDLINE | ID: mdl-31919129
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Receptores de Antígenos de Linfócitos T gama-delta / Butirofilinas / Antígenos de Neoplasias Limite: Humans Idioma: En Revista: Science Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Receptores de Antígenos de Linfócitos T gama-delta / Butirofilinas / Antígenos de Neoplasias Limite: Humans Idioma: En Revista: Science Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália